Literature DB >> 2001056

Cellular immunity in current active pulmonary tuberculosis.

R Andrade-Arzabe1, I V Machado, B Fernandez, I Blanca, R Ramirez, N E Bianco.   

Abstract

A group of 10 patients with recently diagnosed pulmonary TB were studied and compared to 10 bacillus Calmette-Guérin (BCG) immunized healthy individuals. Cellular immune mechanisms were explored in vitro utilizing fresh and precultured peripheral blood mononuclear cells exposed to PHA, PPD, and recall antigens (SK/SD and CA). Proliferative assays were also carried out in the presence of either each patient's serum (autologous serum) or cocultured with CD3(+)-depleted adherent cells. Serum measurements of soluble interleukin-2 (IL-2) receptor and synthesis of IL-2 generated by mononuclear cells stimulated with PPD and SK/SD were also performed. Patient sera were able to inhibit autologous as well as allogeneic cell responses, and a significant adherent cell suppressive effect was observed. As a whole the group of patients showed decreased blast transformation to PPD, preserved proliferative responses to other recall antigens, and a low PPD-induced generation of IL-2. Furthermore, as possible evidence of preactivated T cells, these patients demonstrated high soluble IL-2 receptor serum levels. Early compromise of specific cell-mediated immunity, including IL-2 abnormalities, may be of significance in newly diagnosed pulmonary TB.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001056     DOI: 10.1164/ajrccm/143.3.496

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

1.  Cellular immunity in tuberculous pleural effusions: evidence of spontaneous lymphocyte proliferation and antigen-specific accelerated responses to purified protein derivative (PPD).

Authors:  F Lorgat; M M Keraan; S R Ress
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes.

Authors:  B J Johnson; D N McMurray
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

3.  Value of serum cytokine biomarkers TNF-α, IL-4, sIL-2R and IFN-γ for use in monitoring bacterial load and anti-tuberculosis treatment progress.

Authors:  Wenjuan Nie; Jun Wang; Wei Jing; Wenhui Shi; Qingfeng Wang; Xuerui Huang; Baoyun Cai; Qiping Ge; Lihui Nie; Xiqin Han; Yadong Du; Jing Wang; Ru Guo; Naihui Chu
Journal:  Cytokine X       Date:  2020-05-13

4.  Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritis.

Authors:  A Hamzaoui; K Hamzaoui; A Kahan; A Chabbou
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.